NCT06614153View on ClinicalTrials.gov

Pharmacokinetics,Pharmacodynamics,Efficacy and Safety of HRG2010 in Parkinson's Disease Patients With Motor Fluctuations

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 16, 2023

Primary Completion Date

January 31, 2024

Study Completion Date

March 4, 2024

Conditions

Parkinson's Disease

Interventions

DRUG

HRG2010(I)

DRUG

HRG2010(II)

DRUG

Sustained-release Carbidopa/Levodopa

Trial Locations (1)

100730

Beijing Hospital, Beijing

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT06614153 - Pharmacokinetics,Pharmacodynamics,Efficacy and Safety of HRG2010 in Parkinson's Disease Patients With Motor Fluctuations | Biotech Hunter | Biotech Hunter